SU6668

SU6668 · National Cancer Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SU6668, covering 2013-01-23 to 2013-01-23. Get the full timeline:

Most recent: Clinical Trial Update: SU6668 in Treating Patients With Advanced Solid Tumors [Phase 1]